Neuropathy, Congenital Hypomyelinating, 2 disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

CHN2 MCID: NRP064 MIFTS: 35	Neuropathy, Congenital Hypomyelinating, 2 (CHN2) Categories: Genetic diseases, Neuronal diseases, Rare diseases
Genes Variations Tissues Related diseases Publications Symptoms & Phenotypes Expand all tables

Sources

Aliases & Classifications for Neuropathy, Congenital Hypomyelinating, 2

MalaCards integrated aliases for Neuropathy, Congenital Hypomyelinating, 2:

Name: Neuropathy, Congenital Hypomyelinating, 2 ⁵⁶ ⁷³

Hypomyelinating Neuropathy, Congenital, 2 ⁵⁶ ⁷³

Congenital Hypomyelinating Neuropathy 2 ²⁹ ⁶

Chn2 ⁵⁶ ⁷³

Characteristics:

OMIM:

⁵⁶

Inheritance:
autosomal dominant

Miscellaneous:
variable severity
onset at birth or in utero

HPO:

³¹

neuropathy, congenital hypomyelinating, 2:
Inheritance autosomal dominant inheritance
Onset and clinical course variable expressivity

Classifications:

MalaCards categories:
Global: Genetic diseases Rare diseases
Anatomical: Neuronal diseases

See all MalaCards categories (disease lists)

External Ids:

OMIM ⁵⁶ 618184

OMIM Phenotypic Series ⁵⁶ PS605253

MeSH ⁴³ D015417

MedGen ⁴¹ C4722277 CN257483

SNOMED-CT via HPO ⁶⁸ 111266001 229844004 255385008 more

Sources

Summaries for Neuropathy, Congenital Hypomyelinating, 2

OMIM : ⁵⁶ Congenital hypomyelinating neuropathy-2 is an autosomal dominant neurologic disorder characterized by early-onset hypotonia, severely delayed motor development, muscle weakness with areflexia, and severely decreased nerve conduction velocities (NCV) resulting from improper myelination of axons. The severity is variable: some patients may present at birth with contractures and respiratory insufficiency, whereas others may achieve walking (summary by Warner et al., 1996). CHN shows significant phenotypic overlap with Dejerine-Sottas syndrome (DSS; 145900), which is also a neuropathy with early onset. Some classify the disorders differently, noting that CHN is characterized by hypo- or amyelination resulting from a congenital defect in myelin formation, whereas DSS has features of continuous myelin breakdown, with demyelination and remyelination (summary by Smit et al., 2008). For a discussion of genetic heterogeneity of CHN, see CHN1 (605253). (618184)

MalaCards based summary : Neuropathy, Congenital Hypomyelinating, 2, also known as hypomyelinating neuropathy, congenital, 2, is related to schizophrenia and duodenum adenocarcinoma. An important gene associated with Neuropathy, Congenital Hypomyelinating, 2 is MPZ (Myelin Protein Zero). Affiliated tissues include liver, skeletal muscle and brain, and related phenotypes are scoliosis and respiratory insufficiency due to muscle weakness

UniProtKB/Swiss-Prot : ⁷³ Neuropathy, congenital hypomyelinating, 2: A form of congenital hypomyelinating neuropathy, a neurologic disorder characterized by early-onset hypotonia, areflexia, distal muscle weakness, and very slow nerve conduction velocities (NCV) resulting from improper myelination of axons. In its extreme form, it may present with severe joint contractures or arthrogryposis multiplex congenita and respiratory insufficiency. In less severe cases patients may achieve walking. Patients lack both active myelin breakdown and well-organized onion bulbs on sural nerve biopsies, have absence of inflammation, and show hypomyelination of most or all fibers. CHN2 inheritance is autosomal dominant.

Sources

Related Diseases for Neuropathy, Congenital Hypomyelinating, 2

Diseases in the Neuropathy, Congenital Hypomyelinating, 1, Autosomal Recessive family:

Neuropathy, Congenital Hypomyelinating, 2

Neuropathy, Congenital Hypomyelinating, 3

Diseases related to Neuropathy, Congenital Hypomyelinating, 2 via text searches within MalaCards or GeneCards Suite gene sharing:

#	Related Disease	Score	Top Affiliating Genes
1	schizophrenia	11.5
2	duodenum adenocarcinoma	11.2
3	hepatosplenic t-cell lymphoma	11.2
4	diabetes mellitus, noninsulin-dependent	10.2
5	severe combined immunodeficiency	10.2
6	substance dependence	10.2
7	contractures, pterygia, and spondylocarpotarsal fusion syndrome 1a	9.4	RHO MPZ
8	bardet-biedl syndrome	9.2	RHO MPZ

Graphical network of the top 20 diseases related to Neuropathy, Congenital Hypomyelinating, 2:

Sources

Symptoms & Phenotypes for Neuropathy, Congenital Hypomyelinating, 2

Human phenotypes related to Neuropathy, Congenital Hypomyelinating, 2:

³¹ (show all 14)

#	Description	HPO Source Accession
1	scoliosis ³¹	HP:0002650
2	respiratory insufficiency due to muscle weakness ³¹	HP:0002747
3	skeletal muscle atrophy ³¹	HP:0003202
4	areflexia ³¹	HP:0001284
5	decreased fetal movement ³¹	HP:0001558
6	abnormality of the foot ³¹	HP:0001760
7	hyporeflexia ³¹	HP:0001265
8	decreased motor nerve conduction velocity ³¹	HP:0003431
9	severe muscular hypotonia ³¹	HP:0006829
10	poor head control ³¹	HP:0002421
11	inability to walk ³¹	HP:0002540
12	hypokinesia ³¹	HP:0002375
13	facial diplegia ³¹	HP:0001349
14	delayed ability to walk ³¹	HP:0031936

Symptoms via clinical synopsis from OMIM:

⁵⁶

Skeletal Spine:
scoliosis

Neurologic Peripheral Nervous System:
areflexia
hyporeflexia
decreased motor nerve conduction velocities, severe (less than 10 m/s)
absent sensory conduction
little or no compact myelin seen on sural nerve biopsy
more

Muscle Soft Tissue:
hypokinesia
muscle atrophy
hypotonia, severe
poor fiber type differentiation caused by abnormal innervation seen on muscle biopsy

Skeletal Feet:
foot deformities

Abdomen Gastrointestinal:
poor swallowing due to muscle weakness

Skeletal Hands:
arthrogryposis of the hands

Respiratory:
respiratory insufficiency due to muscle weakness

Neurologic Central Nervous System:
poor head control
inability to walk
delayed walking
delayed motor development, severe

Head And Neck Face:
facial diplegia

Prenatal Manifestations Movement:
decreased fetal movements

Skeletal:
contractures, distal (in some patients)

Clinical features from OMIM:

618184

Sources

Drugs & Therapeutics for Neuropathy, Congenital Hypomyelinating, 2

Search Clinical Trials , NIH Clinical Center for Neuropathy, Congenital Hypomyelinating, 2

Sources

Genetic Tests for Neuropathy, Congenital Hypomyelinating, 2

Genetic tests related to Neuropathy, Congenital Hypomyelinating, 2:

#	Genetic test	Affiliating Genes
1	Congenital Hypomyelinating Neuropathy 2 ²⁹	MPZ

Sources

Anatomical Context for Neuropathy, Congenital Hypomyelinating, 2

MalaCards organs/tissues related to Neuropathy, Congenital Hypomyelinating, 2:

⁴⁰

Liver, Skeletal Muscle, Brain, Kidney, Breast, Bone, T Cells

Sources

Publications for Neuropathy, Congenital Hypomyelinating, 2

Articles related to Neuropathy, Congenital Hypomyelinating, 2:

(show top 50) (show all 157)

#	Title	Authors	PMID	Year
1	Congenital hypomyelinating neuropathy, a long term follow-up study in an affected family. ⁶ ⁵⁶	Smit LS...van Doorn PA	17825553	2008
2	A novel MPZ gene mutation in congenital neuropathy with hypomyelination. ⁵⁶ ⁶	Kochanski A...Hausmanowa-Petrusewicz I	15184631	2004
3	Disturbance of muscle fiber differentiation in congenital hypomyelinating neuropathy caused by a novel myelin protein zero mutation. ⁶ ⁵⁶	Szigeti K...Lupski JR	12953275	2003
4	Congenital hypomyelination due to myelin protein zero Q215X mutation. ⁵⁶	Mandich P...Schenone A	10319895	1999
5	Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. ⁵⁶	Warner LE...Lupski JR	8816708	1996
6	Efficacy and Safety of Dulaglutide by Baseline HbA1c in Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis. ⁶¹	Yu M...Lv XF	32277401	2020
7	A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals. ⁶¹	Riva L...Chanda SK	32511357	2020
8	Identification of a truncated β1-chimaerin variant that inactivates nuclear Rac1. ⁶¹	Casado-Medrano V...Caloca MJ	31871052	2020
9	Candidate Gene and Genome-Wide Association Studies for Circulating Leptin Levels Reveal Population and Sex-Specific Associations in High Cardiovascular Risk Mediterranean Subjects. ⁶¹	Ortega-Azorin C...Corella D	31766143	2019
10	Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants. ⁶¹	Ju C...Turecki G	31594917	2019
11	Efficacy and Safety of Dulaglutide Versus Insulin Glargine in Chinese T2DM Patients: A Subgroup Analysis of a Randomized Trial (AWARD-CHN2). ⁶¹	Li Y...Ji QH	31228090	2019
12	CHN2 Promoter Methylation Change May Be Associated With Methamphetamine Dependence. ⁶¹	Hao L...Hao W	29719347	2017
13	Subtype-Specific Genes that Characterize Subpopulations of Callosal Projection Neurons in Mouse Identify Molecularly Homologous Populations in Macaque Cortex. ⁶¹	Fame RM...Macklis JD	26874185	2017
14	Maternal BMI as a predictor of methylation of obesity-related genes in saliva samples from preschool-age Hispanic children at-risk for obesity. ⁶¹	Oelsner KT...Barkin SL	28068899	2017
15	Multi-electron redox processes at a Zr(iv) center facilitated by an appended redox-active cobalt-containing metalloligand. ⁶¹	Krogman JP...Thomas CM	27326824	2016
16	The synthesis, structure and reactivity of an imine-stabilized carboranylphosphorus(i) compound. ⁶¹	Chan TL...Xie Z	27180610	2016
17	Genome-Wide Interaction with Insulin Secretion Loci Reveals Novel Loci for Type 2 Diabetes in African Americans. ⁶¹	Keaton JM...Bowden DW	27448167	2016
18	Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy. ⁶¹	Agardh E...Ling C	26248552	2015
19	Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility. ⁶¹	Alvi MA...Salto-Tellez M	26315110	2015
20	High-Resolution Array Comparative Genomic Hybridization Utility in Polish Newborns with Isolated Cleft Lip and Palate. ⁶¹	Szczaluba K...Bocian E	25613075	2015
21	Chimerin 2 genetic polymorphisms are associated with non-proliferative diabetic retinopathy in Taiwanese type 2 diabetic patients. ⁶¹	Chen M...Tsai FJ	24854763	2014
22	Genome characterization of sugarcane yellow leaf virus from China reveals a novel recombinant genotype. ⁶¹	Lin YH...Mirkov TE	24395076	2014
23	Influence of model grid resolution on NO2 vertical column densities over East Asia. ⁶¹	Yamaji K...Ohara T	24843914	2014
24	Generation of C(2)F(5)CHN(2) in situ and its first reaction: [3+2] cycloaddition with alkenes. ⁶¹	Mykhailiuk PK	24700600	2014
25	Analysis of common and coding variants with cardiovascular disease in the Diabetes Heart Study. ⁶¹	Adams JN...Bowden DW	24725463	2014
26	Genome-wide association and pharmacological profiling of 29 anticancer agents using lymphoblastoid cell lines. ⁶¹	Brown CC...Motsinger-Reif AA	24444404	2014
27	Evaluation of candidate nephropathy susceptibility genes in a genome-wide association study of African American diabetic kidney disease. ⁶¹	Palmer ND...Bowden DW	24551085	2014
28	β3-chimaerin, a novel member of the chimaerin Rac-GAP family. ⁶¹	Zubeldia-Brenner L...Leskow FC	24430297	2014
29	Integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphoma. ⁶¹	Finalet Ferreiro J...Wlodarska I	25057852	2014
30	Genome-wide association study of atypical psychosis. ⁶¹	Kanazawa T...Yoneda H	24132900	2013
31	Association of a novel polymorphism of the β2-chimaerin gene (CHN2) with smoking. ⁶¹	Barrio-Real L...Caloca MJ	23941981	2013
32	Over-expression of the miRNA cluster at chromosome 14q32 in the alcoholic brain correlates with suppression of predicted target mRNA required for oligodendrocyte proliferation. ⁶¹	Manzardo AM...Butler MG	23747354	2013
33	Cysteine proteinase inhibitors regulate human and mouse osteoclastogenesis by interfering with RANK signaling. ⁶¹	Stralberg F...Lerner UH	23572233	2013
34	Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP. ⁶¹	Mead S...Collinge J	22210626	2012
35	CPVL/CHN2 genetic variant is associated with diabetic retinopathy in Chinese type 2 diabetic patients. ⁶¹	Hu C...Jia W	21911749	2011
36	Genetic associations in diabetic nephropathy: a meta-analysis. ⁶¹	Mooyaart AL...Baelde HJ	21127830	2011
37	Replication study for the association between four Loci identified by a genome-wide association study on European American subjects with type 1 diabetes and susceptibility to diabetic nephropathy in Japanese subjects with type 2 diabetes. ⁶¹	Maeda S...Nakamura Y	20460425	2010
38	Severe insulin resistance and intrauterine growth deficiency associated with haploinsufficiency for INSR and CHN2: new insights into synergistic pathways involved in growth and metabolism. ⁶¹	Suliman SG...Gloyn AL	19720790	2009
39	Characterization of cysteine proteases from the carcinogenic liver fluke, Opisthorchis viverrini. ⁶¹	Kaewpitoon N...Sripa B	18092178	2008
40	Comparison of cysteine peptidase activities in Trichobilharzia regenti and Schistosoma mansoni cercariae. ⁶¹	Kasny M...Horak P	17517170	2007
41	The cysteine proteinase inhibitor Z-Phe-Ala-CHN2 alters cell morphology and cell division activity of Trypanosoma brucei bloodstream forms in vivo. ⁶¹	Scory S...Steverding D	17328798	2007
42	The crystal structure of human dipeptidyl peptidase I (cathepsin C) in complex with the inhibitor Gly-Phe-CHN2. ⁶¹	Molgaard A...Pedersen J	17020538	2007
43	Labelling of four distinct trophozoite falcipains of Plasmodium falciparum by a cystatin-derived probe. ⁶¹	Florent I...Lalmanach G	15899703	2005
44	Characterization of human ARHGAP10 gene in silico. ⁶¹	Katoh M...Katoh M	15375573	2004
45	Osteoclastogenesis is decreased by cysteine proteinase inhibitors. ⁶¹	Brage M...Lerner UH	15003789	2004
46	Molecular and enzymatic properties of a cathepsin L-like proteinase with distinct substrate specificity from northern shrimp (Pandalus borealis). ⁶¹	Aoki H...Watabe S	14574613	2004
47	Microarray analysis of gene-expression profiles in diffuse large B-cell lymphoma: identification of genes related to disease progression. ⁶¹	Nishiu M...Aozasa K	12716467	2002
48	Peptidyl diazomethyl ketones inhibit the human rhinovirus 3C protease: effect on virus yield by partial block of P3 polyprotein processing. ⁶¹	Murray MA...Babe LM	11900346	2001
49	Dipeptide vinyl sulfones suitable for intracellular inhibition of dipeptidyl peptidase I. ⁶¹	Korver GE...Hudig D	11367515	2001
50	Altered expression of cruzipain and a cathepsin B-like target in a Trypanosoma cruzi cell line displaying resistance to synthetic inhibitors of cysteine-proteinases. ⁶¹	Yong V...Scharfstein J	10924756	2000

Sources

Genes for Neuropathy, Congenital Hypomyelinating, 2

Genes related to Neuropathy, Congenital Hypomyelinating, 2 (2 elite genes):

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence	PubmedIds
1	MPZ	Myelin Protein Zero	Protein Coding	1316.82	Molecular basis known ⁵⁶ Pathogenic ⁶ Causative variation ⁷³ Genetic Tests ²⁹ GeneCards inferred via : Disorders Variants (show sections)	15184631 12953275
2	RHO	Rhodopsin	Protein Coding	400	Pathogenic ⁶	17825553

Sources

Variations for Neuropathy, Congenital Hypomyelinating, 2

ClinVar genetic disease variations for Neuropathy, Congenital Hypomyelinating, 2:

⁶ (show all 34) ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎

#	Gene	Name	Type	Significance	ClinVarId	dbSNP ID	GRCh37 Pos	GRCh38 Pos
1	RHO	NM_000539.3(RHO):c.549dup (p.Gln184fs)	duplication	Pathogenic	590911	rs1560046845	3:129251111-129251112	3:129532268-129532269
2	MPZ	MPZ, 3-BP DEL/1-BP INS, NT550	indel	Pathogenic	14192
3	MPZ	NM_000530.8(MPZ):c.371C>A (p.Thr124Lys)	SNV	Pathogenic	14196	rs121913595	1:161276575-161276575	1:161306785-161306785
4	MPZ	NM_000530.8(MPZ):c.200G>A (p.Arg67His)	SNV	Conflicting interpretations of pathogenicity	237875	rs201720099	1:161277082-161277082	1:161307292-161307292
5	MPZ	NM_000530.8(MPZ):c.637G>C (p.Gly213Arg)	SNV	Conflicting interpretations of pathogenicity	246572	rs202176679	1:161275906-161275906	1:161306116-161306116
6	MPZ	NM_000530.8(MPZ):c.*360C>G	SNV	Conflicting interpretations of pathogenicity	876416		1:161275306-161275306	1:161305516-161305516
7	MPZ	NM_000530.8(MPZ):c.-49C>A	SNV	Conflicting interpretations of pathogenicity	293315	rs750777955	1:161279744-161279744	1:161309954-161309954
8	MPZ	NM_000530.8(MPZ):c.*52G>A	SNV	Conflicting interpretations of pathogenicity	293311	rs774701563	1:161275614-161275614	1:161305824-161305824
9	MPZ	NM_000530.8(MPZ):c.*743C>T	SNV	Conflicting interpretations of pathogenicity	293305	rs140992541	1:161274923-161274923	1:161305133-161305133
10	MPZ	NM_000530.8(MPZ):c.*195G>T	SNV	Conflicting interpretations of pathogenicity	293310	rs150182811	1:161275471-161275471	1:161305681-161305681
11	MPZ	NM_000530.8(MPZ):c.*1048A>T	SNV	Conflicting interpretations of pathogenicity	293299	rs71639057	1:161274618-161274618	1:161304828-161304828
12	MPZ	NM_000530.8(MPZ):c.77C>T (p.Pro26Leu)	SNV	Conflicting interpretations of pathogenicity	293314	rs530923760	1:161277205-161277205	1:161307415-161307415
13	MPZ	NM_000530.8(MPZ):c.428C>T (p.Thr143Met)	SNV	Uncertain significance	531684	rs750724650	1:161276518-161276518	1:161306728-161306728
14	MPZ	NM_000530.8(MPZ):c.*1074A>C	SNV	Uncertain significance	293298	rs886045471	1:161274592-161274592	1:161304802-161304802
15	MPZ	NM_000530.8(MPZ):c.*251C>G	SNV	Uncertain significance	293309	rs772995394	1:161275415-161275415	1:161305625-161305625
16	MPZ	NM_000530.8(MPZ):c.*1020G>A	SNV	Uncertain significance	293300	rs886045472	1:161274646-161274646	1:161304856-161304856
17	MPZ	NM_000530.8(MPZ):c.*954C>A	SNV	Uncertain significance	293301	rs372340608	1:161274712-161274712	1:161304922-161304922
18	MPZ	NM_000530.8(MPZ):c.*341A>G	SNV	Uncertain significance	874466		1:161275325-161275325	1:161305535-161305535
19	MPZ	NM_000530.8(MPZ):c.*102C>T	SNV	Uncertain significance	874516		1:161275564-161275564	1:161305774-161305774
20	MPZ	NM_000530.8(MPZ):c.444A>T (p.Glu148Asp)	SNV	Uncertain significance	873574		1:161276502-161276502	1:161306712-161306712
21	MPZ	NM_000530.8(MPZ):c.184A>G (p.Ile62Val)	SNV	Uncertain significance	875495		1:161277098-161277098	1:161307308-161307308
22	MPZ	NM_000530.8(MPZ):c.637G>A (p.Gly213Arg)	SNV	Uncertain significance	638456		1:161275906-161275906	1:161306116-161306116
23	MPZ	NM_000530.8(MPZ):c.*903G>A	SNV	Uncertain significance	876254		1:161274763-161274763	1:161304973-161304973
24	MPZ	NM_000530.8(MPZ):c.*752G>A	SNV	Uncertain significance	876373		1:161274914-161274914	1:161305124-161305124
25	MPZ	NM_000530.8(MPZ):c.*522C>A	SNV	Uncertain significance	875383		1:161275144-161275144	1:161305354-161305354
26	MPZ	NM_000530.8(MPZ):c.*435T>G	SNV	Uncertain significance	875384		1:161275231-161275231	1:161305441-161305441
27	MPZ	NM_000530.8(MPZ):c.*369C>T	SNV	Uncertain significance	876415		1:161275297-161275297	1:161305507-161305507
28	MPZ	NM_000530.8(MPZ):c.*681A>T	SNV	Uncertain significance	293306	rs886045474	1:161274985-161274985	1:161305195-161305195
29	MPZ	NM_000530.8(MPZ):c.*568C>G	SNV	Benign/Likely benign	293308	rs60731755	1:161275098-161275098	1:161305308-161305308
30	MPZ	NM_000530.8(MPZ):c.684C>T (p.Ser228=)	SNV	Benign/Likely benign	129619	rs34307129	1:161275729-161275729	1:161305939-161305939
31	MPZ	NM_000530.8(MPZ):c.504G>A (p.Val168=)	SNV	Benign/Likely benign	293313	rs145592910	1:161276199-161276199	1:161306409-161306409
32	MPZ	NM_000530.8(MPZ):c.*624C>T	SNV	Benign/Likely benign	293307	rs60821801	1:161275042-161275042	1:161305252-161305252
33	MPZ	NM_000530.8(MPZ):c.*761A>G	SNV	Benign	293304	rs16832786	1:161274905-161274905	1:161305115-161305115
34	MPZ	NM_000530.8(MPZ):c.600G>A (p.Gly200=)	SNV	Benign	138242	rs16832790	1:161275943-161275943	1:161306153-161306153

UniProtKB/Swiss-Prot genetic disease variations for Neuropathy, Congenital Hypomyelinating, 2:

⁷³

#	Symbol	AA change	Variation ID	SNP ID
1	MPZ	p.Thr124Lys	VAR_029978	rs121913595

Sources

Expression for Neuropathy, Congenital Hypomyelinating, 2

Search GEO for disease gene expression data for Neuropathy, Congenital Hypomyelinating, 2.

Sources

Pathways for Neuropathy, Congenital Hypomyelinating, 2

Sources

GO Terms for Neuropathy, Congenital Hypomyelinating, 2

Cellular components related to Neuropathy, Congenital Hypomyelinating, 2 according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	integral component of plasma membrane	GO:0005887	8.62	RHO MPZ

Sources

Sources for Neuropathy, Congenital Hypomyelinating, 2

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ EFO

¹⁸ ExPASy

¹⁹ FMA

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ Genetics Home Reference

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HMDB

³¹ HPO

³² ICD10

³³ ICD10 via Orphanet

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ KEGG

³⁷ LifeMap

³⁸ LncRNADisease

³⁹ LOVD

⁴⁰ MalaCards

⁴¹ MedGen

⁴² MedlinePlus

⁴³ MeSH

⁴⁴ MESH via Orphanet

⁴⁵ MGI

⁴⁶ miR2Disease

⁴⁷ NCBI Bookshelf

⁴⁸ NCI

⁴⁹ NCIt

⁵⁰ NDF-RT

⁵¹ NIH Clinical Center

⁵² NIH Rare Diseases

⁵³ NINDS

⁵⁴ Novoseek

⁵⁵ Novus Biologicals

⁵⁶ OMIM

⁵⁷ OMIM via Orphanet

⁵⁸ Orphanet

⁵⁹ PathCards

⁶⁰ PharmGKB

⁶¹ PubMed

⁶² PubMed Health

⁶³ QIAGEN

⁶⁴ R&D Systems

⁶⁵ Reactome

⁶⁶ Sino Biological

⁶⁷ SNOMED-CT

⁶⁸ SNOMED-CT via HPO

⁶⁹ TGDB

⁷⁰ Tocris

⁷¹ UMLS

⁷² UMLS via Orphanet

⁷³ UniProtKB/Swiss-Prot

⁷⁴ Wikipedia

Neuropathy, Congenital Hypomyelinating, 2 (CHN2)

Aliases & Classifications for Neuropathy, Congenital Hypomyelinating, 2

MalaCards integrated aliases for Neuropathy, Congenital Hypomyelinating, 2:

Characteristics:

OMIM:

HPO:

Classifications:

External Ids:

Summaries for Neuropathy, Congenital Hypomyelinating, 2

Related Diseases for Neuropathy, Congenital Hypomyelinating, 2

Diseases in the Neuropathy, Congenital Hypomyelinating, 1, Autosomal Recessive family:

Diseases related to Neuropathy, Congenital Hypomyelinating, 2 via text searches within MalaCards or GeneCards Suite gene sharing:

Graphical network of the top 20 diseases related to Neuropathy, Congenital Hypomyelinating, 2:

Symptoms & Phenotypes for Neuropathy, Congenital Hypomyelinating, 2

Human phenotypes related to Neuropathy, Congenital Hypomyelinating, 2:

Symptoms via clinical synopsis from OMIM:

Clinical features from OMIM:

Drugs & Therapeutics for Neuropathy, Congenital Hypomyelinating, 2

Genetic Tests for Neuropathy, Congenital Hypomyelinating, 2

Genetic tests related to Neuropathy, Congenital Hypomyelinating, 2:

Anatomical Context for Neuropathy, Congenital Hypomyelinating, 2

MalaCards organs/tissues related to Neuropathy, Congenital Hypomyelinating, 2:

Publications for Neuropathy, Congenital Hypomyelinating, 2

Articles related to Neuropathy, Congenital Hypomyelinating, 2:

Genes for Neuropathy, Congenital Hypomyelinating, 2

Genes related to Neuropathy, Congenital Hypomyelinating, 2 (2 elite genes):

Variations for Neuropathy, Congenital Hypomyelinating, 2

ClinVar genetic disease variations for Neuropathy, Congenital Hypomyelinating, 2:

UniProtKB/Swiss-Prot genetic disease variations for Neuropathy, Congenital Hypomyelinating, 2:

Expression for Neuropathy, Congenital Hypomyelinating, 2

Pathways for Neuropathy, Congenital Hypomyelinating, 2

GO Terms for Neuropathy, Congenital Hypomyelinating, 2

Cellular components related to Neuropathy, Congenital Hypomyelinating, 2 according to GeneCards Suite gene sharing:

Sources for Neuropathy, Congenital Hypomyelinating, 2